+Search query
-Structure paper
| Title | Structural basis of SARS-CoV-2 polymerase inhibition by nonnucleoside inhibitor HeE1-2Tyr. |
|---|---|
| Journal, issue, pages | Proc Natl Acad Sci U S A, Vol. 122, Issue 10, Page e2419854122, Year 2025 |
| Publish date | Mar 11, 2025 |
Authors | Florian Kabinger / Valerie Doze / Jana Schmitzová / Michael Lidschreiber / Christian Dienemann / Patrick Cramer / ![]() |
| PubMed Abstract | Targeting the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 with small molecules is a promising therapeutic strategy against COVID-19, but potent and safe inhibitors are lacking. HeE1-2Tyr, a ...Targeting the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 with small molecules is a promising therapeutic strategy against COVID-19, but potent and safe inhibitors are lacking. HeE1-2Tyr, a nonnucleoside inhibitor of Dengue virus RdRp, was also shown to inhibit SARS-CoV-2 RdRp in vitro and to have antiviral activity in cells, but the underlying mechanism remains unclear. Here, we elucidate the molecular mechanism of HeE1-2Tyr-mediated SARS-CoV-2 RdRp inhibition. Biochemical assays confirm that HeE1-2Tyr inhibits RdRp with an IC of 5 µM and show that it competes with RNA binding to RdRp in vitro. Structural analysis using cryo-EM reveals that a stack of three HeE1-2Tyr molecules binds to the RNA binding site of RdRp. The identification of the conserved HeE1-2Tyr binding site and its intriguing inhibition mechanism of three stacked molecules that outcompete RNA may facilitate further development of pan-corona nonnucleoside inhibitors. |
External links | Proc Natl Acad Sci U S A / PubMed:40035759 / PubMed Central |
| Methods | EM (single particle) |
| Resolution | 2.98 Å |
| Structure data | EMDB-52704, PDB-9i81: |
| Chemicals | ![]() ChemComp-6CJ: |
| Source |
|
Keywords | VIRAL PROTEIN / SARS-CoV-2 RdRp Small molecule inhibitor |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors
External links



Keywords